This Event Has Now Run
Thank you to our speakers, sponsors, and delegates who joined us in San Diego! If you are interested in the 2027 event, please get in touch at: info@hansonwade.com
Address Translational & Commercial Challenges to Seamlessly Utilize Liquid Biopsy Technologies to Drive Smarter, Accelerated Oncology Drug Development
The Liquid Biopsy for Precision Oncology Summit, is the leading annual meeting uniting pharma, biotech, diagnostics, consortia, academia and patient voices to accelerate collaboration and progress in the rapidly advancing field of liquid biopsy.
For its 10th year, this meeting delivered unparalleled insights, data, technology updates, and strategies spanning the entire drug development pipeline - from preclinical discovery, through clinical translation, to regulatory approval, reimbursement, and commercial adoption.
If you are working in precision oncology, or need enhanced insights into your patient population, optimized diagnostic and prognostic tools, or earlier detection of disease, this meeting should be considered a staple entry in to your future conference calendar.
Across ctDNA, MRD, multi-omic biomarkers, and novel analytes, you will see how pharma are strategically integrating liquid biopsies into therapeutic pipelines, how diagnostic companies are designing more sensitive assays, and how the field is overcoming barriers to widespread clinical adoption.
What’s more?
Tickets were complimentary* for biopharma.
Attending Companies Included